Detalles de la búsqueda
1.
Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples.
Eur J Clin Microbiol Infect Dis
; 40(8): 1743-1748, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33594599
2.
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
Oncologist
; 25(12): e1869-e1878, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654250
3.
Evaluation of FilmArray respiratory panel multiplex polymerase chain reaction assay for detection of pathogens in adult outpatients with acute respiratory tract infection.
J Infect Chemother
; 24(9): 734-738, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29895452
4.
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Chemotherapy
; 61(2): 93-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26606381
5.
Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy.
Support Care Cancer
; 23(1): 185-90, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25063271
6.
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
Thorac Cancer
; 11(7): 1972-1978, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32462731
7.
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
Thorac Cancer
; 11(2): 389-393, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851428
8.
ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(9): 2244-2256, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31953310
9.
Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.
J Antimicrob Chemother
; 63(1): 109-14, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18931390
10.
Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
Intern Med
; 58(6): 837-841, 2019 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30449789
11.
Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer.
Thorac Cancer
; 10(4): 872-879, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30811109
12.
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
Thorac Cancer
; 10(3): 452-458, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30628188
13.
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201).
Lung Cancer
; 132: 1-8, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097081
14.
Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer.
Thorac Cancer
; 10(9): 1764-1769, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31309738
15.
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Nat Commun
; 10(1): 259, 2019 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30651547
16.
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
Cancer Res
; 65(4): 1541-6, 2005 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15735043
17.
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.
Onco Targets Ther
; 10: 3211-3214, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28721071
18.
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).
Thorac Cancer
; 8(1): 40-45, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27883280
19.
Pulmonary Artery Sarcoma Overexpressing Platelet-derived Growth Factor Receptor α.
Intern Med
; 56(7): 823-826, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28381750
20.
Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib.
Lung Cancer
; 52(2): 253-5, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16554105